SynthesisJournal of managed care & specialty pharmacy2026

Clinical, economic, and quality-of-life outcomes of brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma and B-cell acute lymphoblastic leukemia: A systematic literature review and meta-analysis.

Bijal D Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.